Bisphosphonates in patients with moderate renal impairment

Alexandra Papaioannou

Can bisphosphonates be used in patients with moderate renal impairment? What are the potential adverse effects of these drugs? Is denosumab a better choice in such patients?

Alexandra Papaioannou, MD: Generally, in those with renal impairment who have creatinine clearance <30 mL/min we recommended to avoid bisphosphonates, particularly the IV bisphosphonates. In somebody with creatinine clearance between 15 to 30 mL/min you can consider something like denosumab, but it is really important to make sure that their vitamin D and calcium levels are adequate, because there is a higher risk of hypocalcemia in that group.

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.